Showing results (1771-1780 of 2,048) with videos related to
Sort By:
Pageof 205
Journal of the American College of Emergency Physicians Open|April 18, 2022
Troponin is unrelated to outcomes in heart failure patients discharged from the emergency departmentGregory J Fermann, Jon W Schrock, Phillip D Levy, et al.British Journal of Haematology|November 11, 2021
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapyStephen Booth, Helen M Curley, Csilla Varnai, et al.Nature Medicine|March 1, 2022
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trialAdriaan A Voors, Christiane E Angermann, John R Teerlink, et al.The Journal of Applied Ecology|March 16, 2018
Weed suppression greatly increased by plant diversity in intensively managed grasslands: A continental-scale experimentJohn Connolly, Maria-Teresa Sebastià, Laura Kirwan, et al.JAMA Cardiology|November 18, 2020
Effect of a Self-care Intervention on 90-Day Outcomes in Patients With Acute Heart Failure Discharged From the Emergency Department: A Randomized Clinical TrialSean P Collins, Dandan Liu, Cathy A Jenkins, et al.JACC. Heart Failure|April 12, 2014
Developing therapies for heart failure with preserved ejection fraction: current state and future directionsJaved Butler, Gregg C Fonarow, Michael R Zile, et al.Nature Cancer|March 25, 2022
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO studySean H Lim, Beth Stuart, Debora Joseph-Pietras, et al.European Journal of Heart Failure|May 30, 2020
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of CardiologyOvidiu Chioncel, John Parissis, Alexandre Mebazaa, et al.British Journal of Haematology|April 29, 2022
A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experienceAndrea Kuhnl, Claire Roddie, Amy A Kirkwood, et al.Blood Advances|August 14, 2025
Camidanlumab Tesirine for Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 StudyAlex F Herrera, Stephen M Ansell, Pier Luigi Zinzani, et al.Pageof 205